MD
PERM FY2024-FY2025NAICS 621112
Mark David Levine, M.D., Professional Corporation PERM Filings
Public PERM filing activity, approval signal, filed wage evidence, beneficiary countries, law firms, and role mix for Mark David Levine, M.D., Professional Corporation.
Updated 2026-05-23
PERM filings
8records
Approval rate
62.5%FY2024-FY2025
Median filed wage
$252,500base wage
Denied filings
0PERM records
Top country
CANADA2 filings
LCA filings are not visa approvals or open roles — see why this matters
Public filing data is normalized for browsing. LCA filings are not visa approvals or job openings, PERM filings are not individual green-card success rates, and salary figures generally use the lower bound of filed wage ranges and exclude equity, bonus, and benefits. PERM pages describe employer filing activity and should not be read as legal advice or a prediction of an individual case outcome.
PERM filings over time
Annual PERM filing counts across available fiscal years.
FY2024–FY2025
FY2024: 4FY2025: 4
Top PERM roles
- Psychiatrist8$252,500
Top beneficiary countries
- CANADA2
- INDIA1
- CHINA1
Top law firms
- Geoffrey D Leibl4
- Leibl & Kirkwood PC4
Frequently Asked Questions
How many PERM filings does Mark David Levine, M.D., Professional Corporation have?
Mark David Levine, M.D., Professional Corporation has 8 PERM filings in the available FY2024-FY2025 dataset.
What is the PERM approval rate for Mark David Levine, M.D., Professional Corporation?
The observed PERM approval rate for Mark David Levine, M.D., Professional Corporation is 62.5% based on certified and denied filings in the available dataset.
Which PERM roles appear most often for Mark David Levine, M.D., Professional Corporation?
Common PERM roles for Mark David Levine, M.D., Professional Corporation include Psychiatrist.
Which beneficiary countries appear most often in Mark David Levine, M.D., Professional Corporation PERM filings?
Common beneficiary countries in Mark David Levine, M.D., Professional Corporation PERM filings include CANADA, INDIA, CHINA.